- Chairperson, Regulatory Affairs Professionals Society of Kenya (RAPSK)
- Co-Chair Africa Regulatory Network (ARN) at the IFPMA
- Board Member, Kenya Association of Pharmaceutical Industry (KAPI)
- Board Member, Global Self Care Federation
- Member IFPMA Africa Engagement Committee (until 2024)
- Member, Global Self Care Federation (GSCF) Africa Strategy Group
- Member of the Panel of Experts for the development of the Medicines Scheduling Guidelines by the Pharmacy and Poisons Board (PPB), Kenya
- Member, Pharmaceutical Society of Kenya
- Member, Pharmaceutical Society of Kenya Industry and Regulatory Affairs Committee
- Past Member, IFPMA Regulatory Reliance Taskforce
- Past Member, IFPMA Post Approval Changes Taskforce
- Member, IFPMA Africa Continental Free Trade Area (AfCFTA) Taskforce
- Member, Africa Medicines Agency Task Force (AMATA)
- Member, AUDA-NEPAD AMRH Technical Committee – Medicines Regulatory Reforms Policy (MPRR TC)
- Member, AUDA-NEPAD AMRH Technical Committee – Information Management Systems (IMS - TC)
- Member, AUDA-NEPAD AMRH Technical Committee – Substandard & Falsified Medical Products (SFMP - TC)
- Member, AUDA-NEPAD AMRH Technical Committee – Regulatory Capacity Development (RDC – TC)
- Industry Lead for East African Community (EAC) Medicines Regulatory Harmonization (MRH) procedures, representing KAPI and IFPMA for over 10 years
- Expert and industry spokesperson on serialization, track and trace systems in Kenya, Ethiopia, and West Africa
- Champion for Inclusion, Diversity & Equity (Africa-wide and Global)
Over the last decade, John has authored multiple industry position papers for medical products industry through KAPI and IFPMA on topics including regulatory reliance, regulatory pathways, regulatory agility, and alternative regulatory pathways.
Driven by a commitment to ethical, innovative healthcare, John represents industry in dialogues with regulators, Regional Economic Communities, and international bodies to foster regulatory systems strengthening, regulatory convergence and combat barriers to medicines access.